Sarbani Maitra, MD
Psychiatry · Fairfield, CANPI 1134360647
Payments from drug & device makers
Across 633 payments — averaging $4899.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Vanda Pharmaceuticals Inc.$1.9M
- AbbVie$678K
- Janssen Research & Development, LLC$240K
- Boehringer Ingelheim$209K
- Siemens Medical Solutions USA, Inc.$48K
- Neurocrine Biosciences, Inc.$35K
- plus $20K from 17 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 99 | $1,871,112 |
| AbbVie | 186 | $678,156 |
| Janssen Research & Development, LLC | 21 | $240,375 |
| Boehringer Ingelheim | 10 | $208,555 |
| Siemens Medical Solutions USA, Inc. | 7 | $48,385 |
| Neurocrine Biosciences, Inc. | 52 | $35,174 |
| Boehringer Ingelheim International GmbH | 36 | $8,976 |
| Boehringer Ingelheim RCV GmbH & Co KG | 2 | $2,403 |
| Biohaven Pharmaceutical Holding Company Ltd. | 8 | $2,215 |
| Alkermes, Inc. | 58 | $1,557 |
| Teva Pharmaceuticals USA, Inc. | 50 | $1,320 |
| E.r. Squibb & Sons, L.L.C. | 15 | $802 |
| Otsuka America Pharmaceutical, Inc. | 19 | $492 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 11 | $341 |
| Axsome Therapeutics, Inc. | 10 | $306 |
| Lundbeck LLC | 13 | $281 |
| Indivior Inc. | 10 | $274 |
| Johnson & Johnson | 10 | $271 |
| Sunovion Pharmaceuticals Inc. | 9 | $162 |
| Bioxcel Therapeutics, Inc. | 2 | $116 |
| Bausch Health US, LLC | 3 | $66 |
| Neuronetics, Inc. | 1 | $45 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $16 |
How this compares
$3,101,402 in reported general payments places this provider in the 95th percentile of 4,954 psychiatry providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other psychiatry in Fairfield
- Elly LeeIrvine$49.8M
- Daniel ChuehOrange$17.9M
- Eric ChavezSan Diego$15.5M
- Lara ShirikjianTorrance$12.6M
- John DuffySanta Ana$12M
- Marina BusselPlaya Vista$12M
- Sherry SoefjeOceanside$11.9M
- Steven MacinaHuntington Beach$11.1M
- Wakelin McNeelRosemead$11M
- Donald AndersonBanning$10.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.